Role of the oxidative DNA damage repair gene OGG1 in colorectal tumorigenesis

Journal of the National Cancer Institute

Volumn 105, Issue 16, 2013, Pages 1249-1253

  Smith, Christopher G ^a   West, Hannah ^a   Harris, Rebecca ^a   Idziaszczyk, Shelley ^a   Maughan, Timothy S ^b   Kaplan, Richard ^c   Richman, Susan ^d   Quirke, Philip ^d   Seymour, Matthew ^d   Moskvina, Valentina ^a   Steinke, Verena ^e   Propping, Peter ^e   Hes, Frederik J ^f   Wijnen, Juul ^f   Cheadle, Jeremy P ^a  

^a CARDIFF UNIVERSITY   (United Kingdom)

^b UNIVERSITY OF OXFORD   (United Kingdom)

^c MRC CLINICAL TRIALS UNIT   (United Kingdom)

^d ST JAMES S UNIVERSITY HOSPITAL   (United Kingdom)

^e UNIVERSITY HOSPITAL BONN   (Germany)

^f LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

8 OXOGUANINE DNA GLYCOSYLASE; DNA GLYCOSYLTRANSFERASE; GLYCINE; UNCLASSIFIED DRUG;

ARTICLE; CANCER RISK; CARCINOGENESIS; CELL COUNT; COLORECTAL CANCER; COLORECTAL CARCINOGENESIS; CONTROLLED STUDY; CRYSTAL STRUCTURE; DNA REPAIR; GENE FREQUENCY; GENE LOCUS; GENE MUTATION; GENETIC ASSOCIATION; GENETIC VARIABILITY; HUMAN; INDEL MUTATION; MAJOR CLINICAL STUDY; OPEN READING FRAME; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); SINGLE NUCLEOTIDE POLYMORPHISM;

ADENOMA; ADULT; AGED; AGED, 80 AND OVER; ALLELES; CARCINOMA; CASE-CONTROL STUDIES; COLORECTAL NEOPLASMS; DNA DAMAGE; DNA GLYCOSYLASES; DNA REPAIR; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; GLUTAMIC ACID; GLYCINE; HUMANS; MALE; MIDDLE AGED; MUTATION; ODDS RATIO; OXIDATION-REDUCTION; PENETRANCE; UP-REGULATION;

EID: 84883185736     PISSN: 00278874     EISSN: 14602105     Source Type: Journal    
DOI: 10.1093/jnci/djt183     Document Type: Article

References (41)

1. Kinzler KW, Vogelstein B. Lessons from hereditary colorectal cancer. Cell. 1996;87(2): 159-170.
2. Aaltonen L, Johns L, Jarvinen H, Mecklin J P, Houlston R. Explaining the familial colorectal cancer risk associated with mismatch repair (MMR)-deficient and MMR-stable tumors. Clin Cancer Res. 2007;13(1):356-361.
3. Al-Tassan N, Chmiel NH, Maynard J, et al. Inherited variants of MYH associated with somatic G:C→T:A mutations in colorectal tumors. Nat Genet. 2002;30(2):227-232.
4. Sampson JR, Dolwani S, Jones S, et al. Autosomal recessive colorectal adenomatous polyposis due to inherited mutations of MYH. Lancet. 2003;362(9377):39-41.
5. Houlston RS, Webb E, Broderick P, et al. Meta-analysis of genome-wide association data identifies four new susceptibility loci for colorectal cancer. Nat Genet. 2008;40(12):1426-1435.
6. Houlston RS, Cheadle J, Dobbins SE, et al. Meta-analysis of three genome-wide association studies identifies susceptibility loci for colorectal cancer at 1q41, 3q26.2, 12q13.13 and 20q13.33. Nat Genet. 2010;42(11):973-977.
7. Dunlop MG, Dobbins SE, Farrington SM, et al. Common variation near CDKN1A, POLD3 and SHROOM2 influences colorec-tal cancer risk. Nat Genet. 2012;44(7):770-776.
8. Slupska MM, Baikalov C, Luther WM, Chiang J-H, Wei Y-F, Miller JH. Cloning and sequencing a human homolog (hMYH) of the Escherichia coli mutY gene whose function is required for the repair of oxidative DNA damage. J Bactiol. 1996;178(13):3885-3892.
9. Huycke MM, Gaskins HR. Commensal bacteria, redox stress, and colorectal cancer: mechanisms and models. Exp Biol Med. 2004;229(7):586-597.
10. Bartsch H, Nair J, Owen RW. Exocyclic DNA adducts as oxidative stress markers in colon carcinogenesis: potential role of lipid peroxi-dation, dietary fat and antioxidants. Biol Chem. 2002;383(6):915-921.
11. Roldan-Arjona T, Wei YF, Carter KC, et al. Molecular cloning and functional expression of a human cDNA encoding the antimuta-tor enzyme 8-hydroxyguanine-DNA glyco-sylase. Proc Natl Acad Sci USA. 1997;94(15): 8016-8020.
12. Matsumoto Y, Zhang QM, Takao M, Yasui A, Yonei S. Escherichia coli Nth and human hNTH1 DNA glycosylases are involved in removal of 8-oxoguanine from 8-oxoguanine/guanine mispairs in DNA. Nucleic Acids Res. 2001;29(9):1975-1981.
13. Hazra TK, Izumi T, Kow YW, Mitra S. The discovery of a new family of mammalian enzymes for repair of oxidatively damaged DNA, and its physiological implications. Carcinogenesis. 2003;24(2):155-157.
14. Sakumi K, Furuichi M, Tsuzuki T, et al. Cloning and expression of cDNA for a human enzyme that hydrolyzes 8-oxo-dGTP, a muta-genic substrate for DNA-synthesis. J Biol Chem. 1993;268(31):23524-23530.
15. Evans MD, Dizdaroglu M, Cooke MS. Oxidative DNA damage and disease: induction, repair and significance. Mutat Res. 2004;567(1):1-61.
16. Ischenko AA, Saparbaev MK. Alternative nucleotide incision repair pathway for oxida-tive DNA damage. Nature. 2002;415(6868): 183-187.
17. D'Errico M, Parlanti E, Teson M, et al. The role of CSA in the response to oxida-tive DNA damage in human cells. Oncogene. 2007;26(30):4336-4343.
18. Ropolo M, Degan P, Foresta M, et al. Complementation of the oxidatively damaged DNA repair defect in Cockayne syndrome A and B cells by Escherichia coli formami-dopyrimidine DNA glycosylase. Free Radic Biol Med. 2007;42(12):1807- 1817.
19. D'Errico M, Parlanti E, Teson M, et al. New functions of XPC in the protection of human skin cells from oxidative damage. EMBO J. 2006;25(18):4305-4315.
20. Mazurek A, Berardini M, Fishel R. Activation of human MutS homologs by 8-oxo-guanine DNA damage. J Biol Chem. 2002;277(10):8260-8266.
21. Le Page F, Randrianarison V, Marot D, et al. BRCA1 and BRCA2 are necessary for the transcription-coupled repair of the oxidative 8-oxoguanine lesion in human cells. Cancer Res. 2000;60(19):5548-5552.
22. Sharma S, Phatak P, Stortchevoi A, Jasin M, Larocque JR. RECQ1 plays a distinct role in cellular response to oxidative DNA damage. DNA Repair (Amst). 2012;11(6):537-549.
23. Allinson SL, Dianova II, Dianov GL. DNA polymerase beta is the major dRP lyase involved in repair of oxidative base lesions in DNA by mammalian cell extracts. EMBO J. 2001;20(23):6919-6926.
24. van Loon B, Hubscher U. An 8-oxo-guanine repair pathway coordinated by MUTYH glyco-sylase and DNA polymerase lambda. Proc Natl Acad Sci USA. 2009;106(43):18201-18206.
25. Ide H, Kotera M. Human DNA glycosylases involved in the repair of oxidatively damaged DNA. Biol Pharm Bull. 2004;27(4):480-485.
26. Chen R, Qiu W, Liu Z, et al. Identification of JWA as a novel functional gene responsive to environmental oxidative stress induced by benzo(a)pyrene and hydrogen peroxide. Free Radic Biol Med. 2007;42(11):1704-1714.
27. Bensaad K, Tsuruta A, Selak MA, et al. TIGAR, a p53-inducible regulator of glycoly-sis and apoptosis. Cell. 2006;126(1):107-120.
28. El-Khamisy SF, Masutani M, Suzuki H, Caldecott KW. A requirement for PARP-1 for the assembly or stability of XRCC1 nuclear foci at sites of oxidative DNA damage. Nucleic Acids Res. 2003;31(19):5526-5533.
29. Maughan TS, Adams RA, Smith CG, et al. Addition of cetuximab to oxaliplatin-based first-line combination chemotherapy for treatment of advanced colorectal cancer: results of the randomized phase 3 MRC COIN trial. Lancet. 2011;377(9783):2103-2114
30. Wellcome Trust Case Control Consortium. Genome-wide association study of 14, 000 cases of seven common diseases and 3, 000 shared controls. Nature. 2007;447(7145):661-678
31. Wellcome Trust Case Control Consortium; Australo-Anglo-American Spondylitis Consortium. Association scan of 14, 500 nonsyn-onymous SNPs in four diseases identifies autoimmunity variants. Nat Genet. 2007;39(11): 1329-1337.
32. Dallosso AR, Dolwani S, Jones N, et al. Inherited predisposition to colorectal adenomas caused by multiple rare alleles of MUTYH but not OGG1, NUDT1, NTH1 or NEIL 1, 2 or 3. Gut. 2008;57(9):1252-1255.
33. Morak M, Massdorf T, Sykora H, Kerscher M, Holinski-Feder E. First evidence for digenic inheritance in hereditary colorectal cancer by mutations in the base excision repair genes. Eur J Cancer. 2011;47(7):1046-1055.
34. Garre P, Briceno V, Xicola RM, et al. Analysis of the oxidative damage repair genes NUDT1, OGG1, and MUTYH in patients from mismatch repair proficient HNPCC families (MSS-HNPCC). Clin Cancer Res. 2011;17(7):1701-1712.
35. Mao G, Pan X, Zhu BB, et al. Identification and characterization of OGG1 mutations in patients with Alzheimer's disease. Nucleic Acids Res. 2007;35(8):2759-2766.
36. Sidorenko VS, Grollman A P, Jaruga P, Dizdaroglu M, Zharkov DO. Substrate specificity and excision kinetics of natural polymorphic variants and phosphomimetic mutants of human 8-oxoguanine-DNA glycosylase. FEBS J. 2009;276(18):5149-5162.
37. Blons H, Radicella J P, Laccourreye O, et al. Frequent allelic loss at chromosome 3p distinct from genetic alterations of the 8-oxogua-nine DNA glycosylase 1 gene in head and neck cancer. Mol Carcinog. 1999;26(4):254-260.
38. Bruner SD, Norman DP, Verdine GL. Structural basis for recognition and repair of the endogenous mutagen 8-oxoguanine in DNA. Nature. 2000;403(6772):859-866.
39. Noren Hooten N, Kompaniez K, Barnes J, Lohani A, Evans MK. Poly(ADP-ribose) poly-merase 1 (PARP-1) binds to 8-oxoguanine-DNA glycosylase (OGG1). J Biol Chem. 2011; 286(52):44679-44690.
40. de Souza-Pinto NC, Maynard S, Hashiguchi K, Hu J, Muftuoglu M, Bohr VA. The recombination protein RAD52 cooperates with the excision repair protein OGG1 for the repair of oxidative lesions in mammalian cells. Mol Cell Biol. 2009;29(16):4441-4454.
41. Cheadle J P, Sampson JR. Exposing the MYtH about base excision repair and human inherited disease. Hum Mol Genet. 2003;12(Spec No 2):159-165.